Skip to main content
SpringerLink
Log in

The analysis of the cost and amputation rates of hospitalized diabetic foot infection patients

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Direct and indirect costs of diabetes and its complications figure prominently in health care expenditure globally. The diabetic foot is one of the most common complications of diabetes and is usually associated with neurological and peripheral vascular problems, yielding foot ulcers and infection. The aim of this study was to analyze hospitalized diabetic foot patient costs and amputation rate changes over time. Hospitalized patients with infected diabetic foot ulcerations within a 4-year span, starting in January 2012, were retrospectively evaluated to analyze cost and amputation rate changes over time. One hundred thirty-eight diabetic patients were hospitalized and treated. Major amputation rates tended to increase; however, minor amputation rates tended to decrease over time. Mean cost per patient was $2880. The distribution of the costs according to the years was not significant. Treatment of infected diabetic foot ulceration is challenging and incurs high healthcare costs. Through intensive foot care and multidisciplinary team approaches, major amputation rates have gradually increased in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.

    Article  PubMed  Google Scholar 

  2. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.

    Article  PubMed  Google Scholar 

  3. Number (in Thousands) of Hospital Discharges with a Lower Extremity Condition (LEC) as First-Listed or Secondary Diagnosis and Diabetes as Any Listed Diagnosis, United States, 1988–2007 Available: http://www.cdc.gov/diabetes/statistics/hosplea/diabetes_complications/fig5.html. Accessed 21 Jabuary 2016

  4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.

    Article  PubMed Central  Google Scholar 

  5. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D, Lancet NCD Action Group. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.

    Article  PubMed  Google Scholar 

  6. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E. Infectious Diseases Society of America. Executive summary: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:1679–84.

    Article  PubMed  Google Scholar 

  7. Historical Consumer Price and Wholesale Price Index Numbers with different base years also can be accessed at this section. Available: http://evds.tcmb.gov.tr/yeni/sss/soru-4-tr.html. Accessed 25 January 2016.

  8. Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38:1852–7.

    Article  PubMed  Google Scholar 

  9. Karakoc A, Ersoy RU, Arslan M, Toruner FB, Yetkin I. Change in amputation rate in a Turkish diabetic foot population. J Diabetes Complicat. 2004;18:169–72.

    Article  PubMed  Google Scholar 

  10. Tabur S, Eren MA, Çelik Y, Dağ OF, Sabuncu T, Sayiner ZA, Savas E. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr. 2015;127:45–50.

    Article  PubMed  Google Scholar 

  11. Yesil S, Akinci B, Bayraktar F, Havitcioglu H, Karabay O, Yapar N, Demirdover C, Yener S, Yalcin M, Comlekci A, Eraslan S. Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey. Exp Clin Endocrinol Diabetes. 2009;117:345–9.

    Article  CAS  PubMed  Google Scholar 

  12. Aksoy DY, Gürlek A, Cetinkaya Y, Oznur A, Yazici M, Ozgür F, Aydingöz U, Gedik O. Change in the amputation profile in diabetic foot in a tertiary reference center: efficacy of team working. Exp Clin Endocrinol Diabetes. 2004;112:526–30.

    Article  CAS  PubMed  Google Scholar 

  13. Akcay S, Satoglu IS, Harman E, Kurtulmus A, Kazimoglu C. A retrospective analysis of amputation rates and comorbidity in patients with diabetic foot ulcer. Med Sci. 2012;1:331–40.

    Article  Google Scholar 

  14. Gonen MS, Cakir M, Gonulalan G, Ozturk M, Ipekci SH, Kosker A, Karalezli MN, Eryaman I, Durgut K, Keskin M, Seyhan N. The problems and cost-effectiveness analysis of diabetic foot infections. Turk J Endocrinol Metab. 2012;16:10–3.

    Google Scholar 

  15. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–5.

    Article  PubMed  Google Scholar 

  16. Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ. Lower extremity amputations—a review of global variability in incidence. Diabet Med. 2011;28:1144–53.

    Article  CAS  PubMed  Google Scholar 

  17. Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012;55:1919–25.

    Article  CAS  PubMed  Google Scholar 

  18. Altunbaş HA, Balci MK, Karayalcin U. A retrospective analysis of hospitalized diabetic foot patients in Akdeniz University School of Medicine, Division of Endocrinology. Turk J Endocrinol Metab. 1999;3:123–7.

    Google Scholar 

  19. Inflation rate calculation Available: http://www3.tcmb.gov.tr/enflasyoncalc/enflasyon_anayeni.php. Accessed 25 January 2016.

  20. Keskek SO, Kirim S, Yanmaz N. Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey. Pak J Med Sci. 2014;30:968–71.

    PubMed  PubMed Central  Google Scholar 

  21. Bao X, Yang C, Fang K, Shi M, Yu G, Hu Y. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing. China J Diabetes. 2016. doi:10.1111/1753-0407.12428.

    PubMed  Google Scholar 

  22. Elif A, Onder NT, Kayali S, Keskin Z, Yigit O. Cost analysis per patient in state hospitals according to departments (an example based on Istanbul education and research hospital). Health Care Acad J. 2015;2:40–52.

    Article  Google Scholar 

  23. Hicks CW, Selvarajah S, Mathioudakis N, Perler BA, Freischlag JA, Black 3rd JH, Abularrage CJ. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60:1247–54.

    Article  PubMed  Google Scholar 

  24. Hopkins RB, Burke N, Harlock J, Jegathisawaran J, Goeree R. Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Serv Res. 2015;15:13.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(Suppl 1):107–11.

    Article  PubMed  Google Scholar 

  26. Health Expenditure in OECD countries Available: http://www.oecd.org/els/health-systems/health-expenditure.htm. Accessed 25 January 2016.

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey

    Gül Karagöz, Ayten Kadanalı, Sinan Öztürk, Şule Eren Çakar, Şenol Çomoğlu & Fidan Doğan

  2. Department of Plastic and Reconstructive Surgery, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey

    Sinan Öztürk

Authors
  1. Gül Karagöz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayten Kadanalı
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sinan Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sinan Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Şule Eren Çakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Şenol Çomoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fidan Doğan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gül Karagöz.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karagöz, G., Kadanalı, A., Öztürk, S. et al. The analysis of the cost and amputation rates of hospitalized diabetic foot infection patients. Int J Diabetes Dev Ctries 37, 201–205 (2017). https://doi.org/10.1007/s13410-016-0524-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-016-0524-3

Keywords

Search

Navigation